GlassScriptPhysician profile
John J Burton
NPI 1740275643
$12,265.87
in general payments reported to CMS, 2019-2025
48 companies · $1,557 in 2025
The $1,557 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,639 · 2020: $1,065 · 2021: $2,027 · 2022: $2,071 · 2023: $1,847 · 2024: $2,059 · 2025: $1,557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,463.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,463.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,147.64 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Amgen INC. | $1,130.54 | 2019-2025 | Evenity, Repatha, Prolia |
| Astrazeneca Pharmaceuticals LP | $1,102.07 | 2019-2024 | Farxiga, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,008.23 | 2019-2025 | Jardiance |
| Lilly USA, LLC | $907.06 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $727.95 | 2019-2024 | Vraylar |
| Pfizer INC. | $704.79 | 2019-2025 | |
| Amarin Pharma, INC. | $371.73 | 2019-2022 | |
| Boston Scientific Corporation | $362.94 | 2019-2025 | Watchman Flx, Apollo Esg System |
| Bayer Healthcare Pharmaceuticals INC. | $346.45 | 2021-2024 | |
| Abbott Laboratories | $335.43 | 2019-2025 | Freestyle Libre 3 |
| Esperion Therapeutics, INC. | $323.95 | 2020-2023 | Nexletol |
| Kowa Pharmaceuticals America, INC. | $272.52 | 2020-2025 | Zoryve |
| Astellas Pharma US INC | $234.93 | 2019-2025 | Veozah |
| Eisai INC. | $194.09 | 2021-2025 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Burton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.